Stock Screener App

無料 -

インストール

10.01

0.05% 0.005

after-market

アフターアワーズ： 10.01

Drugs Made In America Acquisition Ii Corp (DMII)

概要ニュース株価時系列ディスカッション予測

Drugs Made In America Acquisition Ii Corp (DMII) 最新ニュース

Beng Kuang Marine Receives SGX Approval for Listing of 57 Million New Shares for Asian Sealand Acquisition - Minichart

Drugs Made In America Acquisition II Corp. Updates CFO and CEO Compensation Agreements and Share Grant Terms - Minichart

Drugs Made In America Acquisition Updates Executive Compensation Agreements - TipRanks

[8-K] Drugs Made In America Acquisition II Corp. Reports Material Event - Stock Titan

Drugs Made in America (NASDAQ: DMAA) details new CEO pay deal - Stock Titan

DRUMMOND VEN: Performance & Quotes, MACK Stock Price on Toronto S.E. Exchange - marketscreener.com

ETFs Investing in Drugs Made In America Acquisition II Corp. Stocks - TradingView

Short Interest in Drugs Made In America Acquisition Corp. (NASDAQ:DMAA) Grows By 8,397.5% - MarketBeat

DMAA | Drugs Made In America Insider Trading - Quiver Quantitative

Illumination Acquisition Corp I: Performance & Quotes, ILLU Stock Price on Nasdaq Exchange - marketscreener.com

AlphaTON Capital Corp. (ALP) - Minichart

DMII Price History for Drugs Made IN America Acquisition II Stock - Barchart.com

DMAAR Price History for Drugs Made IN America Acquisition Corp. Rights Stock - Barchart.com

Centiel AG: Shareholders Board Members Managers and Company Profile | CH0024666528 - marketscreener.com

USDrugAcqII (DMIIU) Stock Mutual Fund Trade (+0.10%) 2026-04-20Market Hype - Cổng thông tin điện tử tỉnh Lào Cai

AmDrug Acq2 (DMII) Stock: Is It a Compelling Buy (Idled) 2026-04-20Rating Change - Cổng thông tin điện tử tỉnh Lào Cai

Is AmericanDrug (DMAAR) stock exposed to downside risk (Selloff Intensifies) 2026-04-20Company Analysis - Cổng thông tin điện tử tỉnh Lào Cai

US Drug Acq (DMAA) Stock Upgrade Alert (Stuck) 2026-04-18Expert Breakout Alerts - Xã Châu Thành

Drugs Made In America Acquisition Corp.: Valuation Ratios, Analysts' Forecasts - marketscreener.com

Vote math updated for Drugs Made In America (DMAA) in proxy amendment - Stock Titan

Drugs Made In America Acquisition II Corp. 10-K Annual Report: Business Strategy, Acquisition Focus, and Management Overview - Minichart

Drugs Made In America Acquisition Corp. (DMAA): SPAC Focusing on AI, Machine Learning, and Pharmaceutical Acquisition Opportunities - Minichart

Drugs Made In America Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Drugs Made In America (NASDAQ: DMAA) details SPAC cash, LOI and risks - Stock Titan

Drugs Made In America Acquisition II Corp. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Drugs Made In America Acquisition II (DMII) logs $4.2M income, flags going-concern risk - Stock Titan

Paloma Acquisition Corp I: Performance & Quotes, PALO Stock Price on Nasdaq Exchange - marketscreener.com

Drugs Made In America Acquisition 10-K: $0 revenue, $5.94M net income, ($0.28M) net loss - TradingView

Drugs Made in America (DMAA) asks investors to extend SPAC deal deadline - Stock Titan

Drugs Made In America Acquisition Corp. (NASDAQ:DMAA) Sees Large Decrease in Short Interest - MarketBeat

Drugs Made In America Acquisition Corp. Auditor Raises 'Going Concern' Doubt - marketscreener.com

MRLN|Inflection Point Acquisition IV Ord Shs Class A|Price:13.660|Chg%:0.08 - TradingKey

Weekly Recap: Is Drugs Made In America Acquisition Corp a momentum stock2026 Stock Rankings & High Conviction Trade Alerts - baoquankhu1.vn

JPMorgan Chase & Co. Buys Shares of 99,690 Drugs Made In America Acquisition Corp. $DMAA - MarketBeat

Aug Chart Watch: What makes Drugs Made In America Acquisition Corp stock attractive today2026 Patterns & AI Forecasted Entry and Exit Points - baoquankhu1.vn

Drugs Made In America Acquisition (NASDAQ:DMAA) Shares Down 0%What's Next? - MarketBeat

Targets Report: Can Drugs Made In America Acquisition Corp Equity Right deliver alphaStop Loss & Weekly Breakout Opportunity Watchlist - baoquankhu1.vn

Drugs Made In America Acquisition Corp.Rights (NQ: DMAAR - The Chronicle-Journal

Drugs Made In America Acquisition Corp. Signs LOI for De-SPAC Merger with Power Analytics Global Corp - Minichart

Power Analytics Global Corp signed a letter of intent to acquire Drugs Made In America Acquisition Corp. in a reverse merger transaction for $1.0 billion. - marketscreener.com

Drugs Made In America Acquisition II Corp. Unit (DMIIU) Competitors - Meyka

Drugs Made in America SPAC Signs Power Analytics LOI - TipRanks

Drugs Made in America Acquisition Corp. signs LOI for de-SPAC with Power Analytics - Investing.com

Drugs Made In America Acquisition CorpEnters Loi For De-Spac With Power Analytics Global CorpSEC Filing - TradingView

Drugs Made in America to pursue de-SPAC with Power Analytics Global at ~$1.0B valuation - TradingView — Track All Markets

De-SPAC LOI values Power Analytics at $1.0B with DMAA (NASDAQ: DMAA) - Stock Titan

Proem Acquisition Corp I: Performance & Quotes, PAAC Stock Price on Nasdaq Exchange - marketscreener.com

Idea Acquisition Corp.: Performance & Quotes, IACO Stock Price on Nasdaq Exchange - marketscreener.com

Willow Lane Acquisition Corp. II: Performance & Quotes, WLII Stock Price on Nasdaq Exchange - marketscreener.com

Why Is Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) Stock Up Today? - Meyka

Death Cross: Can Drugs Made In America Acquisition Corp Equity Right sustain earnings growth2026 Sector Review & Free Daily Entry Point Trade Alerts - baoquankhu1.vn

Chart Watch: Is Drugs Made In America Acquisition Corp Equity Right stock influenced by commodity pricesEarnings Overview Summary & Risk Controlled Swing Alerts - baoquankhu1.vn

Are executives confident in DMA Acq II (DMIIR) Stock | Price at $0.08, Up 17.25%Institutional Grade Stocks - Cổng thông tin điện tử Tỉnh Sơn La

Is AmDrug Acq2 (DMII) Stock in a Downtrend | Price at $9.98, Down 0.05%Trending Momentum Stocks - Cổng thông tin điện tử Tỉnh Sơn La

Drugs Made In America Acquisition II Corp. Announces $1.4 Million Convertible Notes Financing Agreement with Alpha Multi Family Office - Minichart

MercadoLibre, Inc. Launches 2026 Long Term Retention Program for Key Employees (8-K Filing) - minichart.com.sg

Drugs Made In America Acquisition II Corp. enters $300,000 convertible note agreement - Investing.com Australia

Drugs Made In America II Issues Interim Convertible Note - TipRanks

Drugs Made In America Acquisition II Finalizes $1.4M Notes Deal, Adds $300K Interim Convertible - TradingView

$300K zero‑interest note backs Drugs Made In America II (NASDAQ: DMII) - Stock Titan

Drugs Made in America Acquisition II Delays Annual Filing - TipRanks

Drugs Made in America Delays Annual Filing - TipRanks

Late 10-K notice — Drugs Made in America (NASDAQ: DMAA) delays FY2025 filing - Stock Titan

DMII (NASDAQ: DMII) files 12b-25—expects to file 10-K by Apr 15, 2026 - Stock Titan

BCSS

$10.17

0.10%

EVAC

$10.13

0.00%

CEPF

$10.24

0.15%

UMAC

$14.49

2.23%

CCXI

$10.24

0.00%

Yahooで開く | Google で開く | Finviz で開く | マーケットウォッチで開く | エドガーでオープン | ロイターで開く